A new cancer treatment has shown promise in reducing TB growth, particularly in drug-resistant bacteria. The medication, tested in unique cellular models, targets Mycobacterium tuberculosis, the bacteria that causes tuberculosis. It helps initiate natural cell death processes in infected cells. TB kills over 1.6 million people each year, and drug resistance is a growing concern. The researchers are hopeful that host-directed therapies, such as this one, can be a game-changer for infectious diseases. The therapy combines two inhibitors and can control TB growth up to 98%.
-
Uncategorized
Recently govt launched Nikshay Mitra initiative to enable adoption of TB patients has already witnessed 1.7 Lakh affected adopted within three days. The govt’s aim to launch this program is to eradicate TB through a national inclusive phenomenon and to provide adoption, food or vocational aid to every TB-affected person. With 9 Lakh having agreed to participate, the data of patients can be found online, wherein UP has the highest number of 4,416 so far. Nikshay means eradication of Tuberculosis.
